Samil Pharm (000520) — Cash Flow Quality Index

Latest as of June 2024: 5.01x

Samil Pharm (000520) has a Cash Flow Quality Index of 5.01x as of June 2024. Operating cash flow of ₩1.75 Billion exceeds net income of ₩350.31 Million, indicating high earnings quality where cash backs reported profits. Explore Samil Pharm (000520) cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

5.01x
Operating CF / Net Income

Operating Cash Flow

₩1.75 Billion
KRW

Net Income

₩350.31 Million
KRW

Data as of

Jun 2024
Most recent filing

Samil Pharm Cash Flow Quality Index (2013–2023)

Historical Cash Flow Quality Index for Samil Pharm across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Samil Pharm (000520) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Samil Pharm (2013–2023)

Year-by-year earnings quality comparison for Samil Pharm. For live market cap and the full company financial profile, see Samil Pharm (000520) total market value.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2023 7.06x ₩11.75 Billion ₩1.66 Billion ▲ +21.7%
2020 5.80x ₩7.77 Billion ₩1.34 Billion ▼ -56.9%
2019 13.47x ₩10.59 Billion ₩786.26 Million ▲ +111.9%
2016 6.35x ₩5.63 Billion ₩886.60 Million ▲ +28.1%
2015 4.96x ₩2.92 Billion ₩588.37 Million ▲ +1086.3%
2013 -0.50x ₩-3.99 Billion ₩7.93 Billion
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.